TR199801613T2 - Kontrast ajanlar�nda ya da bunlarla ilgili iyile�tirmeler. - Google Patents

Kontrast ajanlar�nda ya da bunlarla ilgili iyile�tirmeler.

Info

Publication number
TR199801613T2
TR199801613T2 TR1998/01613T TR9801613T TR199801613T2 TR 199801613 T2 TR199801613 T2 TR 199801613T2 TR 1998/01613 T TR1998/01613 T TR 1998/01613T TR 9801613 T TR9801613 T TR 9801613T TR 199801613 T2 TR199801613 T2 TR 199801613T2
Authority
TR
Turkey
Prior art keywords
contrast agents
microbubbles
stabilized
product
dispersions
Prior art date
Application number
TR1998/01613T
Other languages
English (en)
Turkish (tr)
Inventor
Dugstad Harald
Klaveness Jo
Rongved Pal
Skurtveit Roald
Braenden Jorun
Original Assignee
Nycomed Imaging A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603466.5A external-priority patent/GB9603466D0/en
Priority claimed from GBGB9611894.8A external-priority patent/GB9611894D0/en
Priority claimed from GBGB9625663.1A external-priority patent/GB9625663D0/en
Application filed by Nycomed Imaging A/S filed Critical Nycomed Imaging A/S
Publication of TR199801613T2 publication Critical patent/TR199801613T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/227—Liposomes, lipoprotein vesicles, e.g. LDL or HDL lipoproteins, micelles, e.g. phospholipidic or polymeric
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Acoustics & Sound (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
TR1998/01613T 1996-02-19 1997-02-19 Kontrast ajanlar�nda ya da bunlarla ilgili iyile�tirmeler. TR199801613T2 (xx)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9603466.5A GB9603466D0 (en) 1996-02-19 1996-02-19 Improvements in or relating to contrast agents
GBGB9611894.8A GB9611894D0 (en) 1996-06-07 1996-06-07 Improvements in or relating to contrast agents
GBGB9625663.1A GB9625663D0 (en) 1996-12-11 1996-12-11 Improvements in or relating to contrast agents

Publications (1)

Publication Number Publication Date
TR199801613T2 true TR199801613T2 (xx) 1998-11-23

Family

ID=27268137

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1998/01613T TR199801613T2 (xx) 1996-02-19 1997-02-19 Kontrast ajanlar�nda ya da bunlarla ilgili iyile�tirmeler.

Country Status (24)

Country Link
US (4) US6221337B1 (enExample)
EP (2) EP1331013A3 (enExample)
JP (1) JP4418033B2 (enExample)
KR (1) KR100500334B1 (enExample)
CN (1) CN1278740C (enExample)
AP (1) AP890A (enExample)
AT (1) ATE238072T1 (enExample)
AU (1) AU726503B2 (enExample)
BG (1) BG102758A (enExample)
CA (1) CA2246779C (enExample)
CZ (1) CZ293986B6 (enExample)
DE (1) DE69721235T2 (enExample)
EA (1) EA001135B1 (enExample)
EE (1) EE04224B1 (enExample)
ES (1) ES2197986T3 (enExample)
HU (1) HU229090B1 (enExample)
IL (1) IL125748A (enExample)
NZ (1) NZ331509A (enExample)
OA (1) OA10839A (enExample)
PL (1) PL328406A1 (enExample)
PT (1) PT881915E (enExample)
SK (1) SK284200B6 (enExample)
TR (1) TR199801613T2 (enExample)
WO (1) WO1997029783A1 (enExample)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU784367B2 (en) * 1996-08-02 2006-03-16 Ge Healthcare As Improvements in or relating to contrast agents
CA2262908A1 (en) * 1996-08-02 1998-02-12 David Johnson Contrast agents for ultrasound imaging of the liver
ATE252916T1 (de) * 1997-08-12 2003-11-15 Bracco Research Sa Verabreichbare formulierugen und ihre anwendung in mri
GB9717476D0 (en) * 1997-08-18 1997-10-22 Nycomed Imaging As Process
GB9717589D0 (en) * 1997-08-19 1997-10-22 Nycomed Imaging As Improvements in or relating to contrast agents
GB9717588D0 (en) * 1997-08-19 1997-10-22 Nycomed Imaging As Improvements in or relating to contrast agents
GB9717542D0 (en) * 1997-08-19 1997-10-22 Nycomed Imaging As Process
GB9726773D0 (en) * 1997-12-18 1998-02-18 Nycomed Imaging As Improvements in or relating to ultrasonagraphy
ATE265525T1 (de) * 1998-04-28 2004-05-15 Amersham Health As Verbesserung von trennungsverfahren
GB9813568D0 (en) 1998-06-23 1998-08-19 Nycomed Imaging As Improvements in or relating to cardiac imaging
US6514209B1 (en) 1999-06-07 2003-02-04 Drexel University Method of enhancing ultrasonic techniques via measurement of ultraharmonic signals
US20030103960A1 (en) * 1999-12-22 2003-06-05 Pierre Philippart Sealant and bone generating product
AU2001266696A1 (en) 2000-06-02 2001-12-11 Bracco Research Usa Compounds for targeting endothelial cells
NO20004795D0 (no) 2000-09-26 2000-09-26 Nycomed Imaging As Peptidbaserte forbindelser
KR100373712B1 (ko) * 2000-12-23 2003-02-25 사회복지법인삼성생명공익재단(삼성서울병원) 초음파 조영제 및 그의 제조방법
US6984373B2 (en) 2000-12-23 2006-01-10 Dyax Corp. Fibrin binding moieties useful as imaging agents
WO2002080774A2 (en) 2001-04-06 2002-10-17 Bracco Research S.A. Method for improved measurement of local physical parameters in afluid-filled cavity
JP2005522422A (ja) * 2002-02-01 2005-07-28 シモダ、バイオテック（プロプライエタリー）リミテッド 医薬組成物
EP2014310B8 (en) 2002-03-01 2012-12-26 Dyax Corp. KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
US7794693B2 (en) 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
US8623822B2 (en) 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
EP1587944A4 (en) 2002-03-01 2007-03-21 Dyax Corp KDR AND VEGF / KDR BINDING PEPTIDES AND THEIR USE FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES
US7211240B2 (en) 2002-03-01 2007-05-01 Bracco International B.V. Multivalent constructs for therapeutic and diagnostic applications
NO20024755D0 (no) * 2002-10-03 2002-10-03 Amersham Health As Metode
KR20050072496A (ko) 2002-11-29 2005-07-11 아머샴 헬스 에이에스 초음파 촬영 방법
US20070128117A1 (en) * 2003-02-04 2007-06-07 Bracco International B.V. Ultrasound contrast agents and process for the preparation thereof
DE602004029010D1 (de) * 2003-02-04 2010-10-21 Bracco Suisse Sa Ultraschall kontrastmittel und verfahren zur erstellung
ES2396368T3 (es) 2003-03-03 2013-02-21 Dyax Corporation Péptidos que se unen específicamente al receptor del HGF (CMET) y usos de los mismos
EP1643972A4 (en) * 2003-06-27 2010-01-20 Smithkline Beecham Corp STABILIZED LIPOSOMAL TOPOTECAN COMPOSITION AND METHOD
US20050019379A1 (en) 2003-07-22 2005-01-27 Kimberly-Clark Worldwide, Inc. Wipe and methods for improving skin health
NO20035401D0 (no) * 2003-12-04 2003-12-04 Amersham Health As Metode
CN1897978B (zh) * 2003-12-22 2011-11-23 博莱科瑞士股份有限公司 具有用于反差成像的活性组分的充气微囊组件
AU2004308756B2 (en) * 2003-12-22 2010-06-24 Bracco Suisse S.A. Gas-filled microvesicle assembly for contrast imaging
US7025726B2 (en) 2004-01-22 2006-04-11 The Regents Of The University Of Nebraska Detection of endothelial dysfunction by ultrasonic imaging
CN101005858A (zh) 2004-08-18 2007-07-25 伯拉考开发股份有限公司 用于反差成像的充气微泡组合物
WO2006044997A2 (en) * 2004-10-15 2006-04-27 The Trustees Of Columbia University In The City Of New York System and method for localized measurement and imaging of viscosity of tissues
WO2006044996A2 (en) * 2004-10-15 2006-04-27 The Trustees Of Columbia University In The City Of New York System and method for automated boundary detection of body structures
CN100574809C (zh) * 2005-01-10 2009-12-30 重庆海扶(Hifu)技术有限公司 一种高强度聚焦超声治疗用氟碳乳剂类助剂及其应用
CN100427142C (zh) * 2005-01-10 2008-10-22 重庆海扶(Hifu)技术有限公司 一种高强度聚焦超声治疗用助剂及其筛选方法
CN100574811C (zh) * 2005-01-10 2009-12-30 重庆海扶(Hifu)技术有限公司 一种高强度聚焦超声治疗用微粒类助剂及其应用
US10687785B2 (en) 2005-05-12 2020-06-23 The Trustees Of Columbia Univeristy In The City Of New York System and method for electromechanical activation of arrhythmias
WO2007035721A2 (en) * 2005-09-19 2007-03-29 The Trustees Of Columbia University In The City Of New York Ultrasound method to open blood brain barrier
MX2008007321A (es) 2005-12-09 2008-09-30 Bracco Int Bv Conjugados fosfolipido de vector dirigido.
EP1797919A1 (en) 2005-12-16 2007-06-20 Bracco Research S.A. Liquid transfer device for medical dispensing containers
DOP2007000020A (es) 2006-01-31 2007-09-15 Bayer Schering Pharma Ag Modulación de la actividad de mdl-1 para el tratamiento de enfermedades inflamatorias
JP5154554B2 (ja) 2006-08-01 2013-02-27 ボストン サイエンティフィック サイムド，インコーポレイテッド 非線形イメージングのためのパルスインバージョンシーケンス
US8150128B2 (en) * 2006-08-30 2012-04-03 The Trustees Of Columbia University In The City Of New York Systems and method for composite elastography and wave imaging
JP5420410B2 (ja) 2006-09-05 2014-02-19 ブラッコ・シュイス・ソシエテ・アノニム ポリマー修飾脂質を含むガス封入微小胞
EP2005970A1 (de) 2007-06-22 2008-12-24 Berlin Science Partners GmbH i.V. Bildgebende Diagnostik durch Kombination von Kontrastmitteln
JP2010005512A (ja) * 2008-06-25 2010-01-14 Kao Corp 微細気泡前駆体組成物
GB0811856D0 (en) * 2008-06-27 2008-07-30 Ucl Business Plc Magnetic microbubbles, methods of preparing them and their uses
WO2010014977A1 (en) 2008-08-01 2010-02-04 The Trustees Of Columbia University In The City Of New York Systems and methods for matching and imaging tissue characteristics
WO2010030819A1 (en) 2008-09-10 2010-03-18 The Trustees Of Columbia University In The City Of New York Systems and methods for opening a tissue
EP2334239A4 (en) * 2008-09-10 2011-10-19 Univ Columbia INSULATION OF MICROBUMS OF A SPECIFIC SIZE OF POLYDISPERSE MICROBUBBLES
US10058837B2 (en) 2009-08-28 2018-08-28 The Trustees Of Columbia University In The City Of New York Systems, methods, and devices for production of gas-filled microbubbles
EP2477550A4 (en) * 2009-09-15 2013-12-04 Univ Columbia SYSTEMS, METHODS AND DEVICES FOR MICROBUBBLES
WO2011035254A1 (en) * 2009-09-21 2011-03-24 Drexel University Stabilized ultrasound contrast agent
EP2480144B1 (en) 2009-09-21 2024-03-06 The Trustees of Columbia University in the City of New York Systems for opening of a tissue barrier
US8834846B2 (en) 2010-05-06 2014-09-16 Bruker Biospin Corporation Fluorescent NIRF activatable probes for disease detection
US9265483B2 (en) 2010-08-06 2016-02-23 The Trustees Of Columbia University In The City Of New York Medical imaging contrast devices, methods, and systems
WO2012136813A2 (en) 2011-04-07 2012-10-11 Universitetet I Oslo Agents for medical radar diagnosis
WO2012162664A1 (en) 2011-05-26 2012-11-29 The Trustees Of Columbia University In The City Of New York Systems and methods for opening of a tissue barrier in primates
AU2013255952B2 (en) 2012-04-30 2018-04-12 Ge Healthcare As Method for filling a container with a foamable composition
JP6420761B2 (ja) 2012-06-26 2018-11-07 ジーイー・ヘルスケア・アクスイェ・セルスカプ 気体マイクロバブルを含む組成物の調製
WO2014059170A1 (en) 2012-10-10 2014-04-17 The Trustees Of Columbia University In The City Of New York Systems and methods for mechanical mapping of cardiac rhythm
WO2014096165A2 (en) 2012-12-21 2014-06-26 Bracco Suisse Sa Gas-filled microvesicles
WO2014142926A1 (en) 2013-03-14 2014-09-18 Empire Technology Development Llc Identification of surgical smoke
CN105050614B (zh) 2013-03-15 2019-04-05 加利福尼亚大学董事会 刺激胆固醇流出的具有降低的毒性的肽
US9247921B2 (en) 2013-06-07 2016-02-02 The Trustees Of Columbia University In The City Of New York Systems and methods of high frame rate streaming for treatment monitoring
US10322178B2 (en) 2013-08-09 2019-06-18 The Trustees Of Columbia University In The City Of New York Systems and methods for targeted drug delivery
US10028723B2 (en) 2013-09-03 2018-07-24 The Trustees Of Columbia University In The City Of New York Systems and methods for real-time, transcranial monitoring of blood-brain barrier opening
GB201405735D0 (en) * 2014-03-31 2014-05-14 Ge Healthcare As Ultrasound precursor preparation method
US10682429B2 (en) 2014-12-18 2020-06-16 Bracco Suisse S.A. Targeted gas-filled microvesicles formulation
US10688199B2 (en) * 2015-06-10 2020-06-23 Teikyo University Theranostic bubble preparation (TB), and method for using same
CN107233583B (zh) * 2016-03-29 2020-04-24 北京飞锐达医疗科技有限公司 一种具有超长持续时间的超声造影剂及其制备方法
GB201821049D0 (en) * 2018-12-21 2019-02-06 Ge Healthcare As Ultrasound contrast agent and methods for use therof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585112A (en) * 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
US5445813A (en) * 1992-11-02 1995-08-29 Bracco International B.V. Stable microbubble suspensions as enhancement agents for ultrasound echography
IN172208B (enExample) * 1990-04-02 1993-05-01 Sint Sa
DE4100470A1 (de) * 1991-01-09 1992-07-16 Byk Gulden Lomberg Chem Fab Echokontrastmittel
GB9106673D0 (en) * 1991-03-28 1991-05-15 Hafslund Nycomed As Improvements in or relating to contrast agents
DE4328642A1 (de) * 1993-08-26 1995-03-02 Byk Gulden Lomberg Chem Fab Ultraschallkontrastmittel
GB9511488D0 (en) * 1995-06-07 1995-08-02 Nycomed Imaging As Improvements in or relating to contrast agents
US5846517A (en) * 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator

Also Published As

Publication number Publication date
AU1884797A (en) 1997-09-02
CA2246779C (en) 2008-04-29
BG102758A (en) 1999-09-30
IL125748A0 (en) 1999-04-11
PL328406A1 (en) 1999-01-18
CZ262598A3 (cs) 1999-05-12
ATE238072T1 (de) 2003-05-15
NZ331509A (en) 2000-04-28
EP1331013A3 (en) 2004-03-24
EP0881915B1 (en) 2003-04-23
CA2246779A1 (en) 1997-08-21
SK112698A3 (en) 1999-04-13
EP0881915A1 (en) 1998-12-09
EP1331013A2 (en) 2003-07-30
AP890A (en) 2000-11-13
AP9801319A0 (en) 1998-09-30
JP4418033B2 (ja) 2010-02-17
CN1213972A (zh) 1999-04-14
US20010010811A1 (en) 2001-08-02
DE69721235D1 (de) 2003-05-28
JP2000511510A (ja) 2000-09-05
WO1997029783A1 (en) 1997-08-21
CN1278740C (zh) 2006-10-11
KR19990082669A (ko) 1999-11-25
AU726503B2 (en) 2000-11-09
EA199800745A1 (ru) 1999-02-25
CZ293986B6 (cs) 2004-09-15
ES2197986T3 (es) 2004-01-16
EE04224B1 (et) 2004-02-16
DE69721235T2 (de) 2004-02-05
US6221337B1 (en) 2001-04-24
SK284200B6 (sk) 2004-10-05
EE9800249A (et) 1999-02-15
IL125748A (en) 2002-05-23
EA001135B1 (ru) 2000-10-30
PT881915E (pt) 2003-09-30
US20050201942A1 (en) 2005-09-15
HK1014872A1 (en) 1999-10-08
OA10839A (en) 2001-08-13
US20030202942A1 (en) 2003-10-30
KR100500334B1 (ko) 2005-09-09
HUP9900813A3 (en) 1999-11-29
HUP9900813A2 (hu) 1999-07-28
HU229090B1 (en) 2013-07-29

Similar Documents

Publication Publication Date Title
TR199801613T2 (xx) Kontrast ajanlar�nda ya da bunlarla ilgili iyile�tirmeler.
Rosing et al. The role of activated human platelets in prothrombin and factor X activation
Madeira et al. Activation energies of the ATPase activity of sarcoplasmic reticulum
IL139112A0 (en) Improvements in or relating to diagnostic/therapeutic agents
Desai et al. Mechanism of heparin activation of antithrombin: Role of individual residues of the pentasaccharide activating sequence in the recognition of native and activated states of antithrombin
Barylko et al. Synergistic activation of dynamin GTPase by Grb2 and phosphoinositides
Griebel et al. Metabolism of poly-β-hydroxybutyrate: effect of mild alkaline extraction on native poly-β-hydroxybutyrate granules
Jain et al. Interfacial catalysis by phospholipase A2: monomeric enzyme is fully catalytically active at the bilayer interface
AU3780497A (en) Improvements in or relating to contrast agents
BR9807043A (pt) Mistura estabilizada que compreende fibrinogênio
BR9808928A (pt) Complexo molecular e liberação controlada dealfa hidroxiácidos
van Dieijen et al. Assembly of the intrinsic factor X activating complex–interactions between factor IXa, factor VIIIa and phospholipid
Attwood et al. The phospholipid-dependence of uridine diphosphate glucuronyltransferase. Reactivation of phospholipase A-inactivated enzyme by phospholipids and detergents
Hazlett et al. Aggregation studies on fluorescein-coupled cobra venom phospholipase A2
Bourin et al. Functional role of the polysaccharide component of rabbit thrombomodulin proteoglycan. Effects on inactivation of thrombin by antithrombin, cleavage of fibrinogen by thrombin and thrombin-catalysed activation of factor V
Turina et al. Activation of the H (+)-ATP synthase in the photosynthetic bacterium Rhodobacter capsulatus.
Garel et al. Binding interactions between two ligands and a monomeric protein: Study on indole, protons and chymotrypsin
Almeida et al. Effect of short-chain primary alcohols on fluidity and activity of sarcoplasmic reticulum membranes
ATE264340T1 (de) Stabilisierung von gefriergetrocknetem kuchen
Ianzini et al. Gamma-irradiation effects on phosphatidylcholine multilayer liposomes: calorimetric, NMR, and spectrofluorimetric studies
Lecompte et al. Membrane penetration of bovine factor V and Va detected by labeling with 5-iodonaphthalene-1-azide.
Inoue et al. Miscibility of binary phospholipid mixtures under hydrated and unhydrated conditions. I. Phosphatidic acids with different acyl chain length
Masotti et al. The effect of ATP on the CD spectrum of membrane fraction from oxyntic cells
Rotenberg et al. Effect of phospholipids on the thermal stability of microsomal UDP-glucuronosyltransferase
Kočevar et al. Improved acylation method enables efficient delivery of functional palmitoylated cystatin into epithelial cells